By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Relmada Therapeutics 

  New York    U.S.A.
Phone: n/a Fax: n/a


Company News
Relmada Therapeutics Announces Filing Of Clinical Trial Application In Canada For Novel Oral Formulations Of Buprenorphine 2/24/2015 6:31:13 AM
Relmada Therapeutics To Present At The 17th Annual BIO CEO & Investor Conference 2/9/2015 11:52:09 AM
Relmada Therapeutics Selects MepiGel Formulations To Advance Into Clinical Studies 2/4/2015 8:52:22 AM
Relmada Therapeutics To Present At 11th Annual Noble Financial Capital Markets Equity Conference 1/16/2015 9:53:53 AM
Relmada Therapeutics Reaches Midway Point In Dose Escalation For Phase One Study Of Novel NMDA Receptor Antagonist D-Methadone 1/13/2015 9:37:49 AM
Relmada Therapeutics To Present At OneMedForum In San Francisco 1/7/2015 9:22:36 AM
Relmada Therapeutics To Provide Corporate Update At 2015 Biotech Showcase™ In San Francisco 1/6/2015 10:59:34 AM
Relmada Therapeutics Doses First Cohort Of Subjects In Human Clinical Trial Of D-Methadone 12/22/2014 9:07:42 AM
Relmada Therapeutics Announces Results Of Annual Shareholders Meeting 12/19/2014 7:41:08 AM
Relmada Therapeutics Nominated For Buzz Of BIO Contest At The 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference 12/5/2014 12:43:15 PM